IRIS
DI BONAVENTURA, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.768
EU - Europa 6.028
AS - Asia 3.570
SA - Sud America 200
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 6
Totale 16.600
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.710
CN - Cina 1.262
SG - Singapore 1.219
IT - Italia 1.203
IE - Irlanda 994
UA - Ucraina 984
GB - Regno Unito 791
SE - Svezia 693
TR - Turchia 692
FR - Francia 454
DE - Germania 374
IN - India 218
FI - Finlandia 196
RU - Federazione Russa 179
BR - Brasile 174
VN - Vietnam 49
HK - Hong Kong 42
AT - Austria 34
MX - Messico 27
CA - Canada 25
CZ - Repubblica Ceca 22
JP - Giappone 20
BE - Belgio 18
NL - Olanda 18
ES - Italia 17
CH - Svizzera 16
EU - Europa 11
BD - Bangladesh 10
IR - Iran 9
KR - Corea 7
AR - Argentina 6
EC - Ecuador 6
IL - Israele 6
IQ - Iraq 6
PL - Polonia 6
TH - Thailandia 6
ZA - Sudafrica 6
GR - Grecia 4
RS - Serbia 4
UZ - Uzbekistan 4
AU - Australia 3
CL - Cile 3
DK - Danimarca 3
EG - Egitto 3
LB - Libano 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
RO - Romania 3
TW - Taiwan 3
UY - Uruguay 3
AL - Albania 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
LT - Lituania 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
PK - Pakistan 2
PT - Portogallo 2
SA - Arabia Saudita 2
TN - Tunisia 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BY - Bielorussia 1
BZ - Belize 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
JM - Giamaica 1
JO - Giordania 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
MK - Macedonia 1
NG - Nigeria 1
NO - Norvegia 1
PR - Porto Rico 1
SI - Slovenia 1
SN - Senegal 1
TJ - Tagikistan 1
VA - Santa Sede (Città del Vaticano) 1
Totale 16.600
Salva come PNG Salva come JPEG
Città #
Chandler 1.323
Jacksonville 1.198
Dublin 990
Singapore 769
Dearborn 642
Southend 574
Princeton 475
Izmir 376
Nanjing 342
Beijing 234
Ashburn 231
Chieti 200
Wilmington 184
Cambridge 182
Santa Clara 144
The Dalles 131
Nanchang 125
Altamura 120
Ann Arbor 113
Boardman 89
Kunming 70
Rome 64
Pescara 60
Shenyang 60
Hebei 59
Los Angeles 57
Dong Ket 49
Munich 47
Jiaxing 45
Hong Kong 41
Woodbridge 41
Tianjin 40
Washington 40
Moscow 38
Norwalk 36
New York 30
Vienna 30
Milan 29
Changsha 27
Pune 24
Hangzhou 23
Grevenbroich 20
Jinan 20
San Mateo 19
Hefei 18
Nuremberg 18
Brussels 17
Orange 17
São Paulo 17
Zhengzhou 17
Houston 16
Ancona 15
Augusta 15
Guangzhou 15
Helsinki 15
Brno 14
Düsseldorf 14
Kocaeli 14
Palermo 14
Seattle 14
Civitanova Marche 13
Lanzhou 13
Auburn Hills 12
Falls Church 12
Teramo 12
Vittuone 12
Changchun 11
Shanghai 11
Spoltore 11
Catania 10
Ferrara 10
Napoli 10
Toronto 10
Varallo 9
Amsterdam 8
Chicago 8
Ningbo 8
Segrate 8
Geneva 7
Simi Valley 7
Ascoli Piceno 6
Bologna 6
Chengdu 6
Ciudad de Villa de Álvarez 6
Coimbatore 6
Council Bluffs 6
L'aquila 6
London 6
Melfi 6
Putignano 6
Rio de Janeiro 6
Salerno 6
Taizhou 6
Walnut 6
Bellaterra 5
Castel Gandolfo 5
Dhaka 5
Fuzhou 5
Lappeenranta 5
Monfalcone 5
Totale 9.977
Salva come PNG Salva come JPEG
Nome #
Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp. pasteurianus 195
Streptococcus dysgalactiae subsp. equisimilis: two cases of tonsillitis. 160
Effetto post-antibiotico di levofloxacina e grepafloxacina nei confronti di Stenotrophomonas maltophilia. 155
Attività battericida ed anti-biofilm di peptidi antimicrobici verso patogeni multi-resistenti isolati da pazienti con fibrosi cistica. 138
Unusual oropharyngeal asymptomatic manifestations caused by atypical pathogens detected by PCR into altered ecosystems of an infertile couple. 134
Addition of teicoplanin or vancomycin for the treatment of documented bacteremia due to gram-positive cocci in neutropenic patients with hematological malignancies: Microbiological, clinical and economic evaluation 128
Fatal sepsis by Klebsiella pneumoniae in a patient with systemic lupus erythematosus: the importance of postmortem microbiological examination for the ex post diagnosis of infection. 125
Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance. 111
Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm 108
Colonic adenoma-associated Escherichia coli express specific phenotypes 107
Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients. 106
Phylogenetic relationships, biofilm formation, motility, antibiotic resistance and extended virulence genotypes among Escherichia coli strains from women with community-onset primitive acute pyelonephritis 103
Detection of Helicobacter pylori by PCR on gastric biopsy specimens taken for CP test: comparison with histopathological analysis. 100
Monitoraggio microbiologico di aria e superfici in ambiente di prime cure chirurgiche di ambulatorio INAIL. 100
Absence of Helicobacter pylori in tonsillar swabs from dyspeptic patients. 99
Biofilm formation by Stenotrophomonas maltophilia: modulation by quinolones, trimethoprim-sulfamethoxazole, and ceftazidime. 98
Meticillin-heteroresistant Staphylococcus pasteuri from an apheresis platelet product 98
Antibiotic resistance and biofilm in Stenotrophomonas maltophilia isolates from cystic fibrosis and non-cystic fibrosis patients 98
Adhesion and biofilm formation by Staphylococcus aureus clinical isolates under conditions relevant to the host: Relationship with macrolide resistance and clonal lineages 98
In vitro microbiology studies on a new peritoneal dialysis connector 94
Role of excessive inflammatory response to Stenotrophomonas maltophilia lung infection in DBA/2 mice and implications for cystic fibrosis. 94
Two cases of vaginitis caused by itraconazole-resistant saccharomyces cerevisiae and a review of recently published studies. 93
Analisi proteomica del biofilm formato da un ceppo di Stenotrophomonas maltophilia isolato da fibrosi cistica. 93
A European perspective on intravascular catheter-related infections: report on the microbiology workload, aetiology and antimicrobial susceptibility (ESGNI-005 Study). 92
Biofilm microbici come sistema dinamico in risposta allo stress ambientale. Approcci innovativi nella prevenzione e formulazione di nuove strategie terapeutiche integrate 91
Accuracy of flagella’s staining in the diagnosis of Helicobacter pylori infection: comparative study with the hystology, culture, and rapid urease test. 91
An overview of various typing methods for clinical epidemiology of the emerging pathogen Stenotrophomonas maltophilia. 91
Comparison of Etest, agar dilution, broth microdilution and disk diffusion methods for testing in vitro activity of levofloxacin against Staphylococcus spp. isolated from neutropenic cancer patients 89
Misidentification of ampicillin-sulbactam heteroresistance in Acinetobacter baumannii strains from ICU patients 89
Alterazione dei livelli tessutali di ioni metallici in un modello murino di infezione polmonare da Stenotrophomonas maltophilia. 89
Peptide dendrimers as “lead compounds” for the treatment of chronic lung infections by Pseudomonas aeruginosa in cystic fibrosis patients: In vitro and in vivo studies 89
Produzione di biofilm in ceppi di Listeria monocytogenes isolati da matrice ittica: correlation con motilità ed idrofobicità cellulare. 88
Comparison of the E test to agar dilution and broth microdilution methods for quantitative antimicrobial susceptibility testing of Helicobacter pylori. 88
An overview on streptococcus bovis/streptococcus equinus complex isolates: Identification to the species/subspecies level and antibiotic resistance 88
Salmonella typhimurium-endocarditis secondary to an acquired environmental infection: a case report. 87
Risk of misidentification of Enterobacter aerogenes inducible cephalosporinases. 87
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 87
Accuratezza di Etest per lo studio di attività in vitro di combinazioni tra fluorochinoloni e cefalosporine di terza generazione verso Pseudomonas aeruginosa. 86
A novel biotechnology product for the degradation of biofilm-associated polysaccharides produced by Streptococcus mutans 86
null 85
Evaluation of the E Test for Antimicrobial Susceptibility Testing of Pseudomonas aeruginosa Isolates from Patients with Long-Term Bladder Catheterization 85
Pan-azole-resistant Candida guilliermondii from a leukemia patient's silent funguria 85
Effect of levofloxacin on Stenotrophomonas maltophilia biofilm and its relationship with SmeDEF multidrug efflux pump expression under conditions relevant to the cystic fibrosis lung 85
Effetto di concentrazioni sub-inibenti di moxifloxacina su Stenotrophomonas maltophilia isolati da fibrosi cistica 84
Comparative in vitro activity of levofloxacin and ciprofloxacin against bacterial isolates from neutropenic patients. 84
Usefulness of Leifson staining method in diagnosis of Helicobacter pylori infection. 84
Cell surface hydrophobicity, motility, and biofilm formation of Stenotrophomonas maltophilia clinical isolates. 83
Serum and mucosal cytokine profiles in patients with active Helicobacter pylori and ischemic heart disease: is their a relationship ? 83
Ulcer infection by ESbetaL-producing Proteus mirabilis: a case report. 83
First report of an acute purulent maxillary sinusitis caused by Pseudomonas aeruginosa secondary to dental implant placement in an immunocompetent patient. 83
Aumentati livelli mucosali gastrici di IL-1alfa, IL-6 ed IL-8 in pazienti Helicobacter pylori-positivi affetti da cardiopatia ischemica. 83
Discrepancies between E-test and agar dilution methods for testing metronidazole susceptibility of Helicobacter pylori (T. Alarcon, D. Domingo, M. Lopez-Brea). Author’s Reply. 83
Isolamento di Actinobacillus actinomycetemcomitans nella placca sottogengivale di pazienti portatori di apparecchiature ortodontiche 83
Helicobacter pylori Outer Membrane Vesicles (OMVs) as DNA shuttles and structural components of biofilm EPS 83
Stenotrophomonas maltophilia Phenotypic and Genotypic Diversity during a 10-year Colonization in the Lungs of a Cystic Fibrosis Patient 83
A new challenge in cystic fibrosis antimicrobial therapy: activity of electrochemically synthesized silver nanoparticles against planktonic and biofilm cells of bacterial pathogens 83
Management and triage of women in follow-up for low-grade cervical disease: association of DNA and RNA-Based methods 82
Antibiotico-resistenza di gram-negativi isolati in Terapia Intensiva nel triennio 1996-1998. 82
Sensibilità in vitro ai fluorichinoloni di Stenotrophomonas maltophilia isolati da pazienti neutropenici. 82
Evaluation of antibacterial and antibiofilm mechanisms by usnic acid against methicillin-resistant Staphylococcus aureus 82
Effect of environmental factors on biofilm formation by clinical Stenotrophomonas maltophilia strains. 81
Accuratezza di E test nella determinazione in vitro della sensibilità di stafilococchi isolati da pazienti neutropenici verso levofloxacina. 81
Infection of recurrent calcaneal ulcer caused by a biofilm-producer Myroides odoratimimus strain. 81
Myroides odoratimimus Forms Structurally Complex and Inherently Antibiotic-Resistant Biofilm in a Wound-Like in vitro Model. 81
Identificazione di ceppi di Acinetobacter baumannii appartenenti a cloni epidemici mediante sequenziamento di geni coinvolti nella produzione di biofilm. 80
Determination of ciprofloxacin and levofloxacin in human sputum collected from cystic fibrosis patients using microextraction by packed sorbent-high performance liquid chromatography photodiode array detector 80
Evolution of Stenotrophomonas maltophilia in Cystic Fibrosis Lung over Chronic Infection: A Genomic and Phenotypic Population Study 80
Isolation of colistin-resistant Hafnia alvei. 80
Influenza di fattori abiotici sulla produzione di biofilm da parte di Stenotrophomonas maltophilia. 79
Virulence factors of Stenotrophomonas maltophilia, an emergent pathogen associated to cystic fibrosis. 79
Anaerobiosi ed ambiente acido influenzano l’attività in vitro di colistina nei confronti del biofilm formato da ceppi di Pseudomonas aeruginosa isolati da pazienti affetti da fibrosi cistica. 79
Microbial cooperation in cystic fibrosis: Stenotrophomonas maltophilia significantly modulates Pseudomonas aeruginosa virulence. 79
Normal breathing releases SARS-CoV-2 into the air 79
In vitro activity of levofloxacin against planktonic and biofilm Stenotrophomonas maltophilia lifestyles under conditions relevant to pulmonary infection in cystic fibrosis, and relationship with SmeDEF multidrug efflux pump expression 79
In Vitro Viability of External Eye Microbial Flora in Hydroxy-Propyl-Methylcellulose 78
Slime production by clinical isolates of Blastoschizomyces capitatus from patients with hematological malignancies and catheter-related fungemia. 78
Subinhibitory concentrations ofmoxifloxacin decrease adhesion and biofilm formation of Stenotrophomonasmaltophilia from cystic fibrosis. 78
Ottimale sopravvivenza di Actinobacillus actinomycetemcomitans sotto varie condizioni di trasporto. 78
Accuratezza di E test per il monitoraggio dell’antibiotico-sensibilità di Pseudomonas aeruginosa isolati da pazienti sottoposti a cateterismo vescicale. 78
Attività in vitro di levofloxacina verso isolati clinici da pazienti neutropenici. 78
Valutazione dell’espressione delle oncoproteine di Papillomavirus nella gestione e nel triage delle donne in follow-up per lesioni di basso grado. 78
Nuovi sistemi emocolturali automatici, ESP 128 (Difco) e Bact/Alert (Organon Teknika): analisi comparativa. 78
An unexpected isolate of Hafnia alvei withreduced susceptibility to cefoxitin. 78
A case ofpharyngitis caused by Streptococcus pneumoniae. 78
Giving Drugs a Second Chance: Antibacterial and Antibiofilm Effects of Ciclopirox and Ribavirin against Cystic Fibrosis Pseudomonas aeruginosa Strains 78
Eparina sodica stimola la formazione di biofilm da parte di Providencia stuartii. 77
Optimal combination of media for primary isolation of Helicobacter pylori from gastric biopsy specimens. 77
Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients. 77
Effetto dello swimming e della idrofobicità superficiale di Stenotrophomonas maltophilia sull’adesività e sulla formazione di biofilm su polistirene. 76
Multidrug-resistant Escherichia fergusonii: a case of acutecystitis. 76
Stenotrophomonas maltophilia virulence and specific variations in trace elements during acute lung infection: implications in cystic fibrosis. 76
D-BMAP18 Antimicrobial Peptide Is Active In vitro, Resists to Pulmonary Proteases but Loses Its Activity in a Murine Model of Pseudomonas aeruginosa Lung Infection 76
New insights in Staphylococcus pseudintermedius pathogenicity: antibiotic-resistant biofilm formed by a human wound-associated strain. 76
Methicillin-resistant Staphylococcus pseudintermedius infection in a bone marrow transplant recipient 76
Staphylococcus pasteuri bacteraemia in a patient with leukaemia. 75
Contribution of the Leifson stain to the detection of Helicobacter pylori from antral biopsy specimens. 75
Stenotrophomonas maltophilia mutant lacking flagella remains virulent in DBA/2N mice but is less efficient in stimulating TNF-α expression 75
Attività in vitro di fluorochinoloni nei confronti del biofilm prodotto da Stenotrophomonas maltophilia. 74
Frequency of detection of Actinobacillus actinomycetemcomitans in young patients during fixed orthodontic therapy. 74
E-test method for detecting antibiotic synergy against Pseudomonas aeruginosa from neutropenic patients: a cost-effective approach. 74
Totale 8.913
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.875
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.875
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020331 0 0 0 0 0 0 0 0 0 0 299 32
2020/20211.464 217 26 257 33 124 266 20 33 116 212 53 107
2021/20221.270 40 47 34 218 107 22 43 111 122 40 143 343
2022/20233.433 288 423 215 416 341 652 203 261 441 42 99 52
2023/20241.468 122 75 90 46 116 381 368 71 16 48 10 125
2024/20252.758 248 614 464 115 88 146 136 159 472 184 132 0
Totale 17.576